• Home
  • Editorial Board
  • Articles
    • Editorials
    • Guest Articles
  • News
    • Featured
    • Biotech News
  • Interviews
    • Interviews – Academia
    • Interviews – Industry
  • Issues – Archives
  • Subscribe
  • Contact
Facebook Twitter Instagram
Trending
  • CDC Boss kicked out in RFK Jr.’s War on Corruption in pharma and healthcare
  • Prof. Rajeev Varshney FRS, now joins Australian Academy of Science
  • Dr. Cyrus S. Poonawalla, SII unveiled the newly built School for Hearing Impaired in Pune
  • AdFalciVax: ICMR’s New Malaria Vaccine: Hope or Premature Hype?”
  • The Sudden Deaths and COVID Vaccines: A Critical Analysis of the ICMR and AIIMS Studies
  • KGMU Scandal: Dr. Tulika Chandra Exposed in Crore Rupee Forgery and Scam
  • Zydus to launch market-specific dosage variants of Semaglutide, MD says
  • Biocon Biologics Launches Nepexto, Etanercept Biosimilar in Australia
Wednesday, October 8
Facebook Twitter Instagram LinkedIn
Biotech Express
  • Home
  • Editorial Board
  • Articles
    • Editorials
    • Guest Articles
  • News
    • Featured
    • Biotech News
  • Interviews
    1. Interviews – Academia
    2. Interviews – Industry
    Featured
    04/01/20241

    Interview: Reach to common man is the heart and soul of India International Science Festival- Dr. Arvind C Ranade Chief Coordinator, IISF- 2023

    Recent
    04/01/2024

    Interview: Reach to common man is the heart and soul of India International Science Festival- Dr. Arvind C Ranade Chief Coordinator, IISF- 2023

    22/05/2023

    Prof Rajeev Varshney becomes the 4th Indian Agricultural Scientist to be elected as Fellow of the Royal Society

    26/07/2022

    We are making best hygiene solutions through Biotech applications: Dr Rachna Dave, founder MicroGO

  • Issues – Archives
  • Subscribe
  • Contact
Biotech Express
You are at:Home»SARS- CoV2 & COVID-19 Updates»Molnupiravir First pill to treat Covid gets approval in UK

Molnupiravir First pill to treat Covid gets approval in UK

0
By Biotech Express on 05/11/2021 SARS- CoV2 & COVID-19 Updates

Molnupiravir, developed by the US drug companies Merck, Sharp and Dohme (MSD) and Ridgeback Biotherapeutics, is the first antiviral medication for Covid which can be taken as a pill rather than injected or given intravenously.

The UK has agreed to purchase 480,000 courses with the first deliveries expected in November.

Initially it will be given to both vaccinated and unvaccinated patients through a national study, with extra data on its effectiveness collected before any decision to order more.

The drug needs to be given within five days of symptoms developing to be most effective.

It’s not immediately clear how it will be distributed so quickly by the NHS. It’s thought some care homes may be offered supplies while other elderly or vulnerable patients may be prescribed it by their GP after testing positive for Covid.

The UK regulator, the MHRA, said the tablet had been authorised for use in people who have mild to moderate Covid and at least one risk factor for developing severe illness such as obesity, old age, diabetes or heart disease.

The organisation’s chief executive, June Raine, described it as “another therapeutic to add to our armoury against Covid-19”.

Earlier clinical trials of molnupiravir on 775 patients who had recently caught Covid found:

  • 7.3% of those given the drug were hospitalised
  • that compares with 14.1% of patients who were given a placebo or dummy pill
  • there were no deaths in the molnupiravir group, but eight patients who were given a placebo in the trial later died of Covid

The results were published in a press release and have not yet been peer-reviewed.

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
Biotech Express
  • Website
  • Facebook
  • Twitter
  • LinkedIn

ISSN: 2454-6968 | Biotech Express Magazine publishes articles in the field of biotechnology and allied sciences in a way that have never been presented earlier. It publishes Editorials, Guest Articles, Reports, Interviews, Current News of Govt. Academics and Business, Research Highlights and Notifications of Events, Jobs, Research Proposals in the field of Biotechnology, Biological Sciences, Life Sciences, Microbiology, Biochemistry, Neurosciences, Genetics, Medical Sciences, BioPharma etc.

Related Posts

Covishield was dangerous and Covaxin was like placebo, they all fooled us for their own benefits: Vaccine Expert Prof Guntaka Ramareddy, India’s first recombinant vaccine developer

Chinese virologist who was first to share COVID-19 genome sleeps on street after lab

Blood Clots due to AstraZeneca/Covishield vaccine: Biotech Express readers would have known this already

Leave A Reply Cancel Reply

Current Issue – September 2025
Biotech Express – e-ISSN: 2454-6968

Editorial Board

For Authors – Article Submission and Guidelines

Peer Review Policies

License and Copyright

Advertisement

Recent Posts
  • CDC Boss kicked out in RFK Jr.’s War on Corruption in pharma and healthcare 21/09/2025
  • Prof. Rajeev Varshney FRS, now joins Australian Academy of Science 20/09/2025
  • Dr. Cyrus S. Poonawalla, SII unveiled the newly built School for Hearing Impaired in Pune 19/09/2025
  • AdFalciVax: ICMR’s New Malaria Vaccine: Hope or Premature Hype?” 18/09/2025
  • The Sudden Deaths and COVID Vaccines: A Critical Analysis of the ICMR and AIIMS Studies 17/09/2025
  • KGMU Scandal: Dr. Tulika Chandra Exposed in Crore Rupee Forgery and Scam 16/09/2025
  • Zydus to launch market-specific dosage variants of Semaglutide, MD says 15/09/2025
  • Biocon Biologics Launches Nepexto, Etanercept Biosimilar in Australia 15/09/2025
  • India launched its first National Biofoundry Network 15/09/2025
  • India has 94 Biotech Incubators across 25 states over 13 years 15/09/2025
Archives
Categories
  • Articles
  • Biotech News
  • Controversial
  • Editorials
  • Events
  • Featured
  • Guest Articles
  • Interviews
  • Interviews – Academia
  • Interviews – Industry
  • News-Industry
  • News-Research
  • Policies
  • SARS- CoV2 & COVID-19 Updates
  • Start-ups
About Us

About Biotech Express

Advisory and Editorial Board

Contact Us

Submission Policy and Guidelines

Submission policies

 

 

Follow us on Social Media
  • Facebook
  • Twitter
  • YouTube
We use cookies to help provide and enhance our service and tailor content and ads. By continuing you agree to the use of cookies. Copyright © 2013-2025 Biotech Express except certain content provided by third parties.

Type above and press Enter to search. Press Esc to cancel.